NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Net Equity Issued and Repurchased (2020)

Updated

NovaBridge Biosciences (NBP) reported Net Equity Issued and Repurchased of $200,000 for FY2025, compared with -$335,000 in FY2024.

Analysis

NovaBridge Biosciences (NBP) Net Equity Issued and Repurchased (2020) Analysis & Trends

Dating back to FY2017, NovaBridge Biosciences' Net Equity Issued and Repurchased record includes 9 years.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -79.4% (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual Net Equity Issued and Repurchased since FY2022.
  • According to Business Quant data, Net Equity Issued and Repurchased came in at -$335,000 in FY2024, -$8.24 million in FY2023, $3.91 million in FY2022 (-96.6%) and $114.95 million in FY2021 (-78.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 123.38 Mn
API Access

NovaBridge Biosciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NBP&period=max&api_key=YOUR_API_KEY